NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 42-50

  Sonoda, K H ^a   Faunce, D E ^a   Taniguchi, M ^a   Exley, M ^a   Balk, S ^a   Stein Streilein, J ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; EYE; FEMALE; IMMUNOLOGICAL TOLERANCE; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE;

EID: 0035172782     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.42     Document Type: Article

References (77)

1. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
2. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
3. Fas and fas ligand: lpr and gld mutations
4. T cells in inflammatory bowel disease: Protective and pathogenic roles
5. Post-thymectomy autoimmunity: Abnormal T-cell homeostasis
6. Immune regulation and the eye: A dangerous compromise
7. Immune deviation in relation to ocular immune privilege
8. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments
9. Fas ligand-induced apoptosis as a mechanism of immune privilege
10. Identification of α-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor
11. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor
12. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products
13. Identification of transforming growth factor-β as an immunosuppressive factor in aqueous humor
14. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen
15. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen: Evidence for active suppression of IgG2-secreting B lymphocytes
16. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties
17. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells
18. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen: Evidence of two functionally and phenotypically distinct T-suppressor cell populations
19. CD1 reactive NKT cells are required for development of systemic tolerance through an immune privileged site
20. Mouse CD1-specific NK1 T cells: Development, specificity, and function
21. - T cells in mice and humans
22. + T cell populations
23. + T cells
24. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
25. - α/β T cells demonstrates preferential use of several V β genes and an invariant TCR α chain
26. -T cells
27. - T cells
28. + T cells by CD1-expressing cortical thymocytes
29. + T lymphocytes
30. + T cell development and early IL-4 production in CD1-deficient mice
31. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
32. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
33. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1
34. Alterations in cytokine production following intraocular injection of soluble protein antigen: Impairment in IFN-γ and induction of TGF-β and IL-4 production
35. A novel role for TGF-β and IL-10 in the induction of immune privilege
36. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis
37. Signalling through NK1.1 triggers NK cells to die but induces NKT cells to produce interleukin-4
38. A simplified, competitive RT-PCR method for measuring rat IFN-γ mRNA expression
39. Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response
40. Interleukin-10
41. IL-10 immunosuppression in transplantation
42. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10 mediated pathways in tumor-bearing mice
43. The role of IL-10 in crossregulation of TH1 and TH2 responses
44. IL-10: A potential therapy for allergic inflammation?
45. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury
46. A deficiency of placental IL-10 in preeclampsia
47. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
48. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
49. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells
50. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection
51. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
52. Induction of tolerance by IL-10-treated dendritic cells
53. Studies of delayed systemic effects of ultraviolet B radiation (UVR) on the induction of contact hypersensitivity. 2. Evidence that interleukin-10 from UVR-treated epidermis is the critical mediator
54. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10
55. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
56. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo
57. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
58. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β
59. IL-4 and IL-10 are both required for the induction of oral tolerance
60. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
61. Interleukin-10 inhibits the capacity of synovial macrophages to function as antigen-presenting cells
62. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
63. On the mechanisms by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation
64. TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells
65. Neutralizing antibodies against Escherichia coli and Vibrio cholerae enterotoxins in human mild from a developing country
66. Cytokines that regulate autoimmune responses
67. IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis
68. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β
69. +) T cells established from murine tumor-infiltrating lymphocytes
70. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium
71. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells
72. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein
73. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis
74. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
75. + NK T cells associated with disease development in autoimmune-prone mice
76. +-like thymocytes in the NOD mouse
77. - T-cell deficiency and IDDM in NOD/Lt mice